申请人:FUKUMOTO Shoji
公开号:US20100094000A1
公开(公告)日:2010-04-15
The present invention relates to
wherein each symbol is as defined in the specification. The compound has a superior mineralocorticoid receptor antagonistic action and is useful as an agent for the prophylaxis or treatment of a disease or condition mediated by the mineralocorticoid receptor activation.
本发明涉及其中每个符号如规范中定义的。该化合物具有优越的矿物皮质激素受体拮抗作用,并可用作通过矿物皮质激素受体激活介导的疾病或病况的预防或治疗剂。